Core Insights - Earth Science Tech, Inc. has engaged Hayden IR to enhance its investor relations and market awareness initiatives, following the successful completion of its FINRA 15c-211 clearance, which supports the company's strategy to scale its businesses into cash-generating entities [1][2] Company Overview - Earth Science Tech operates as a strategic holding company focused on value creation through the acquisition and management of its subsidiaries, which include compounding pharmaceuticals, telemedicine, and real estate development [5][10] - The company's subsidiaries include RxCompoundStore.com, Peaks Curative, Avenvi, Mister Meds, and others, each contributing to its diversified business model [5][10] Financial Performance - In the first half of fiscal 2026, Earth Science Tech reported revenues of $17.8 million, net income of $1.4 million, and operating cash flow of $1.18 million, with gross margins exceeding 70% [3] - The company is noted to have significant operating leverage, indicating potential for higher earnings with rationalized expenses [3] Strategic Initiatives - The partnership with Hayden IR aims to develop a comprehensive investor relations program, focusing on clear communication of the company's strategy, performance, and long-term value proposition [2] - Hayden IR will assist in outreach to both institutional and retail investors, corporate access initiatives, and support for public disclosures and market education [2] Market Positioning - The CEO of Earth Science Tech emphasizes the importance of clearly communicating the company's current operations and growth strategy to the investment community as it enters a critical phase of market repositioning [2]